Publications
Detailed Information
Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Seog-Yun | - |
dc.contributor.author | Yoo, Eun J. | - |
dc.contributor.author | Cho, Nam-Yun | - |
dc.contributor.author | Kim, Nayoung | - |
dc.contributor.author | Kang, Gyeong H. | - |
dc.date.accessioned | 2012-05-23T04:24:30Z | - |
dc.date.available | 2012-05-23T04:24:30Z | - |
dc.date.issued | 2009-12 | - |
dc.identifier.citation | JOURNAL OF PATHOLOGY; Vol.219 4; 410-416 | ko_KR |
dc.identifier.issn | 0022-3417 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76317 | - |
dc.description.abstract | CpG island hypermethylation and genomic DNA hypomethylation are found not only in gastric cancers but also in associated premalignant lesions. Helicobacter pylori infection induces aberrant CpG island hypermethylation in gastric mucosae. However, little is known about the relationship between H. pylori infection and aberrant methylation in premalignant lesions. The present study characterized methylation changes in a subset of genes and repetitive DNA elements (ALU, LINE-1, SAT2) and examined their relationship with H. pylori infection in premalignant lesions of gastric cancers. We performed MethyLight analysis of 25 genes and SAT2 and COBRA analysis of ALU and LINE-1 in 212 gastric tissue samples. H. pylori infection was closely associated with enhanced hypermethylation of CpG island loci in chronic gastritis samples, but this association was not found among intestinal metaplasias, gastric adenomas and gastric cancers. The number of methylated genes was greater in intestinal metaplasia and gastric adenoma samples than in chronic gastritis samples, regardless of H. pylori infection. Methylation of repetitive DNA elements in gastric lesions generally decreased with progression of the gastric lesion along the multistep carcinogenesis. No difference was noted in the number of methylated genes in chronic gastritis or intestinal metaplasia between gastric cancer patients and non-cancer subjects. In conclusion, we found that there was no enhanced CpG island hypermethylation in gastric cancer and premalignant lesions in association with H. pylori infection and our findings suggest that CpG island hypermethylation and repetitive DNA hypomethylation are enhanced with progression of the gastric lesion through the multistep carcinogenesis, regardless of the status of H. pylori infection. Copyright (C) 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | JOHN WILEY & SONS LTD | ko_KR |
dc.subject | chronic gastritis | ko_KR |
dc.subject | gastric cancer | ko_KR |
dc.subject | Helicobacter pylori | ko_KR |
dc.subject | DNA methylation | ko_KR |
dc.subject | CpG islands | ko_KR |
dc.title | Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 박석윤 | - |
dc.contributor.AlternativeAuthor | 조남윤 | - |
dc.contributor.AlternativeAuthor | 김나영 | - |
dc.identifier.doi | 10.1002/path.2596 | - |
dc.citation.journaltitle | JOURNAL OF PATHOLOGY | - |
dc.description.citedreference | Qian XM, 2008, CANCER LETT, V263, P107, DOI 10.1016/j.canlet.2007.12.023 | - |
dc.description.citedreference | Yoo EJ, 2008, VIRCHOWS ARCH, V452, P515, DOI 10.1007/s00428-008-0596-7 | - |
dc.description.citedreference | Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X | - |
dc.description.citedreference | Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707 | - |
dc.description.citedreference | Kaise M, 2008, HELICOBACTER, V13, P35 | - |
dc.description.citedreference | Lauwers GY, 2007, GASTROENTEROL CLIN N, V36, P813, DOI 10.1016/j.gtc.2007.08.008 | - |
dc.description.citedreference | Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142 | - |
dc.description.citedreference | Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106 | - |
dc.description.citedreference | LAUWERS GY, 2007, GASTROENTEROL CLIN N, V36, pR6 | - |
dc.description.citedreference | Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436 | - |
dc.description.citedreference | Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135 | - |
dc.description.citedreference | Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145 | - |
dc.description.citedreference | Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096 | - |
dc.description.citedreference | Sato F, 2006, CANCER, V106, P483, DOI 10.1002/cncr.21657 | - |
dc.description.citedreference | Vauhkonen M, 2006, BEST PRACT RES CL GA, V20, P651, DOI 10.1016/j.bpg.2006.03.016 | - |
dc.description.citedreference | Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472 | - |
dc.description.citedreference | Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987 | - |
dc.description.citedreference | Jemal A, 2004, CA-CANCER J CLIN, V54, P8 | - |
dc.description.citedreference | Yamanaka M, 2003, INT J CANCER, V106, P382, DOI 10.1002/ijc.11227 | - |
dc.description.citedreference | Kang GH, 2003, LAB INVEST, V83, P635, DOI 10.1097/01.LAB.0000067481.08984.3F | - |
dc.description.citedreference | Bariol C, 2003, AM J PATHOL, V162, P1361 | - |
dc.description.citedreference | Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651 | - |
dc.description.citedreference | Waki T, 2002, AM J PATHOL, V161, P399 | - |
dc.description.citedreference | Terry MB, 2002, SEMIN RADIAT ONCOL, V12, P111, DOI 10.1053/srao.30814 | - |
dc.description.citedreference | Asaka M, 2001, HELICOBACTER, V6, P294 | - |
dc.description.citedreference | Rashid A, 2001, AM J PATHOL, V159, P1129 | - |
dc.description.citedreference | Leung WK, 2001, CANCER, V91, P2294 | - |
dc.description.citedreference | Kang GH, 2001, CANCER RES, V61, P2847 | - |
dc.description.citedreference | Shimoyama T, 2000, VIRCHOWS ARCH, V436, P585 | - |
dc.description.citedreference | Asaka M, 1997, GASTROENTEROLOGY, V113, pS56 | - |
dc.description.citedreference | Cravo M, 1996, GUT, V39, P434 | - |
dc.description.citedreference | FORMAN D, 1995, ALIMENT PHARM THERAP, V9, P71 | - |
dc.description.citedreference | SATO F, 1995, AM J SURG PATHOL S1, V19, pS37 | - |
dc.description.citedreference | STEMMERMANN GN, 1994, CANCER, V74, P556 | - |
dc.description.tc | 18 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.